Signal active
Bio
Dorothy Margolskee, MD, is a Managing Director of Foresite Capital and member of the investment team.
Dorothy joined Foresite in 2012 and has overseen the development of Foresite’s research and development evaluation group. Dorothy has worked with Jim for the last 14 years, previously at Prospect Ventures as a Managing Director in charge of Research, and now at Foresite Capital. In this capacity, Dorothy built an early version of the Foresite Capital investment technical review process, rigorously analyzing biotechnology company portfolios on the basis of scientific validation, clinical efficacy and safety, manufacturing readiness and FDA regulatory risk. Earlier, Dorothy had 15 years of drug development experience at Merck Research Labs, ultimately becoming a Senior Vice President with responsibility for a wide variety of clinical development programs and project planning. In particular, she was deeply involved in the design and execution of several vaccine programs, including Gardisil, RotaTeq, Varivax and Zostavax. Dorothy received an MRL Divisional Scientific Award in 1998 for developing one of Merck's largest drugs, Singulair. In addition, she led the team that designed and implemented the advanced AIDS program during the development of Crixivan, one of the first HIV protease inhibitors that revolutionized the treatment of HIV infection.
Prior to joining Merck, Dorothy received an M.D. from Johns Hopkins Medical School where she was elected to Alpha Omega Alpha and a B.S. from Harvard University where she graduated summa cum laude. She is boarded in both Internal Medicine and Pulmonary, and completed her residency at the Johns Hopkins Hospital and fellowship training at UCSF.
Location
Voorhees, New Jersey, United States, North America
Social
Primary Organization
2011
158
49
60
51-100
Financial Services, Venture Capital, Finance, Service Industry, Funding Platform
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Dorothy Margolskee is the Managing Director at Foresite Capital, based in United States, North America. With a background in Financial Services, Dorothy Margolskee has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
1
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Jan 08, 2021 | Affinivax | Series C - Affinivax | Foresite Capital | 226.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.